Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ATN-161 acetate

Copy Product Info
😃Good
Catalog No. T10398LCas No. 904763-58-2
Alias ATN-161 acetate(262438-43-7 Free base), ATN161 acetate, Ac-PHSCN-NH2 acetate

ATN-161 acetate, a pentapeptide compound derived from the synergistic region of fibronectin, is a non-competitive integrin-alpha5 antagonist with antitumor activity that attenuates the pathology of caerulein-induced acute pancreatitis.

ATN-161 acetate

ATN-161 acetate

Copy Product Info
😃Good
Purity: 98.27%
Catalog No. T10398LAlias ATN-161 acetate(262438-43-7 Free base), ATN161 acetate, Ac-PHSCN-NH2 acetateCas No. 904763-58-2
ATN-161 acetate, a pentapeptide compound derived from the synergistic region of fibronectin, is a non-competitive integrin-alpha5 antagonist with antitumor activity that attenuates the pathology of caerulein-induced acute pancreatitis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$195In StockIn Stock
5 mg$483In StockIn Stock
10 mg$692In StockIn Stock
25 mg$1,080In StockIn Stock
50 mg$1,490In StockIn Stock
100 mg$1,970-In Stock
200 mg$2,690-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.27%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
ATN-161 acetate, a pentapeptide compound derived from the synergistic region of fibronectin, is a non-competitive integrin-alpha5 antagonist with antitumor activity that attenuates the pathology of caerulein-induced acute pancreatitis.
In vitro
The treatment regimen of ATN-161 acetate in combination with 5-FU was able to significantly inhibit the proliferation of tumor cells compared to control and monotherapy. In addition, the combination treatment significantly increased the proportion of TUNEL-positive tumor cells, while monotherapy failed to increase TUNEL-positive cells. ATN-161 acetate significantly reduced the number of cancer cells after 48 hours of culture (21% reduction) compared to the control group. [1]
ATN-161 acetate prevented vascular endothelial growth factor-induced migration and capillary formation of hCECs, but had no significant effect on proliferation. Starting at 100 nM, ATN-161 acetate decreased the number of cells migrating in response to VEGF in a dose-dependent manner (compared to the VEGF group). [2]
In vivo
Injection of ATN-161 acetate after laser photocoagulation reduced choroidal neovascularization (CNV) leakage and neovascularization with an inhibitory effect comparable to that of AF564. [2]
SynonymsATN-161 acetate(262438-43-7 Free base), ATN161 acetate, Ac-PHSCN-NH2 acetate
Chemical Properties
Molecular Weight657.7
FormulaC25H39N9O10S
Cas No.904763-58-2
SmilesC(C)(O)=O.C(N[C@@H](CC1=CN=CN1)C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(N)=O)=O)CS)=O)CO)=O)(=O)[C@H]2N(C(C)=O)CCC2
Relative Density.no data available
SequenceAc-Pro-His-Ser-Cys-Asn-NH2.CH3CO2H
Sequence ShortPHSCN
Storage & Solubility Information
Storagekeep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ATN-161 acetate | purchase ATN-161 acetate | ATN-161 acetate cost | order ATN-161 acetate | ATN-161 acetate chemical structure | ATN-161 acetate in vivo | ATN-161 acetate in vitro | ATN-161 acetate formula | ATN-161 acetate molecular weight